EXSNY catalysts

    Catalysts and events linked to EXSNY, newest first.

    EXSNY stock catalysts and risks

    Latest published review: 2026-10-20

    DevelopmentTransmission channelEvidenceCondition to watch
    Exosens Raises 2026 EBITDA Guidance to €192M on Image Intensifier Tube Ramp
    2026-09-17 · Up
    operating margin expansion via high-margin defense electro-optics production rampExosens raised 2026 revenue guidance to €558-570M and adjusted EBITDA to €186-192M on production ramp.Not recorded
    Exosens Raises 2026 Revenue and EBITDA Guidance on Defense Production Ramp
    2026-09-17 · Up
    earnings multiple expansion and EBITDA margin upgrade on defense order deliveryExosens raised 2026 revenue targets to €558-570M and adjusted EBITDA to €186-192M on image tube production ramp.Not recorded
    Exosens Raises 2026 Revenue and EBITDA Outlook on Production Ramp
    2026-09-17 · Up
    guidance upgrade and EBITDA margin expansionRaised 2026 revenue to €558-570M and EBITDA to €186-192M.Not recorded

    Do these developments change your position?

    Review EXSNY alongside your other holdings and identify which decision deserves attention first.

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    DateCardAvg 5d

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month